These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 32659761

  • 1. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points.
    Eshragh N, Doan LV, Connelly KJ, Denniston S, Willis S, LaFranchi SH.
    Horm Res Paediatr; 2020; 93(2):128-136. PubMed ID: 32659761
    [Abstract] [Full Text] [Related]

  • 2. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 3. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS, Rassi TO, Araujo RF, Pezzuti IL, Rodrigues AS, Bachega TASS, Silva IN.
    J Pediatr Endocrinol Metab; 2019 May 27; 32(5):499-504. PubMed ID: 31028712
    [Abstract] [Full Text] [Related]

  • 4. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
    Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A.
    J Pediatr; 1997 Jan 27; 130(1):128-33. PubMed ID: 9003862
    [Abstract] [Full Text] [Related]

  • 5. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A.
    Pediatrics; 2001 Oct 27; 108(4):E68. PubMed ID: 11581476
    [Abstract] [Full Text] [Related]

  • 6. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M.
    Eur J Endocrinol; 2009 Aug 27; 161(2):285-92. PubMed ID: 19451212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY, Yee JK, Hicks RA, Mao CS, Lee WN.
    J Perinatol; 2017 Mar 27; 37(3):283-287. PubMed ID: 27929529
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS, Allen DB, Hoffman GL.
    J Pediatr; 2005 Oct 27; 147(4):493-8. PubMed ID: 16227036
    [Abstract] [Full Text] [Related]

  • 20. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G, García de la Rosa I, González Reyes EC, Rubio Torres A, Quintana Guerra JM, Hernández Marín M, Pérez Mora PL, Feal Carballo S, Lafita Delfino Y, Pupo Infante M, Castells Martínez EM, Rosabal Poloshkov A, Hernández Pérez L.
    Clin Chim Acta; 2018 Oct 27; 485():311-315. PubMed ID: 30006291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.